BNP Paribas Financial Markets
GNCA

BNP Paribas Financial Markets’s Genocea Biosciences, Inc. GNCA Stock Holding History

BNP Paribas Financial Markets’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,755
Closed -$14.7K – 4517
2018
Q1 		$14.7K Buy
1,755
+1,006
+134% +$8.35K ﹤0.01% 3968
2017
Q4 		$6.95K Buy
749
+400
+115% +$4.02K ﹤0.01% 4052
2017
Q3 		$4.08K Sell
349
-26
-7% -$987 ﹤0.01% 4006
2017
Q2 		$15.7K Buy
+375
New +$18.1K ﹤0.01% 3789
2016
Q1 		– Sell
-638
Closed -$26.9K – 3332
2015
Q4 		$26.9K Buy
638
+32
+5% +$1.52K ﹤0.01% 3183
2015
Q3 		$33.2K Buy
606
+413
+214% +$41K ﹤0.01% 3122
2015
Q2 		$21.2K Buy
193
+181
+1,508% +$16.8K ﹤0.01% 3005
2015
Q1 		$1.14K Buy
+12
New +$847 ﹤0.01% 3541
2014
Q4 		– Sell
-52
Closed -$3.74K – 3629
2014
Q3 		$3.74K Buy
52
+17
+49% +$1.86K ﹤0.01% 3876
2014
Q2 		$5.17K Buy
+35
New +$5.31K ﹤0.01% 2566

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets's GNCA Position: Q2 2018 in Review

BNP Paribas Financial Markets sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 1,755 shares — an estimated $14.7K sold.

BNP Paribas Financial Markets first reported a position in GNCA in Q2 2014 and held it in 10 quarters. The position peaked at $33.2K in Q3 2015. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • BNP Paribas Financial Markets reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,755 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $14.7K.
  • BNP Paribas Financial Markets first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 10 quarters.
  • BNP Paribas Financial Markets's Genocea Biosciences, Inc. position peaked at $33.2K in Q3 2015.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2018, filed 25 Jul 2018.